An increase of CD163-positive macrophages was present after HCT (p = 0.0022), in EBV-positive cases (p = 0.008) and in polymorphic compared to monomorphic PTLD, confirming previous reports [23, 42]. Here, CD163 is linked to post-transplant lymphoproliferative disease.